These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

822 related articles for article (PubMed ID: 8618665)

  • 1. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study.
    Myers RH; Schaefer EJ; Wilson PW; D'Agostino R; Ordovas JM; Espino A; Au R; White RF; Knoefel JE; Cobb JL; McNulty KA; Beiser A; Wolf PA
    Neurology; 1996 Mar; 46(3):673-7. PubMed ID: 8618665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of apolipoprotein E genetic variation in Alzheimer's disease in Indian population: a meta-analysis.
    Agarwal R; Tripathi CB
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):575-82. PubMed ID: 25551132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
    JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
    Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
    Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
    Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
    JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
    Chen Q; Wang T; Kang D; Chen L
    Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation.
    Slooter AJ; Tang MX; van Duijn CM; Stern Y; Ott A; Bell K; Breteler MM; Van Broeckhoven C; Tatemichi TK; Tycko B; Hofman A; Mayeux R
    JAMA; 1997 Mar; 277(10):818-21. PubMed ID: 9052712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APOE epsilon2/epsilon3/epsilon4 and promoter gene variants with dementia but not cardiovascular mortality in old age.
    Heijmans BT; Slagboom PE; Gussekloo J; Droog S; Lagaay AM; Kluft C; Knook DL; Westendorp RG
    Am J Med Genet; 2002 Jan; 107(3):201-8. PubMed ID: 11807900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E polymorphism in elderly Chilean people with Alzheimer's disease.
    Quiroga P; Calvo C; Albala C; Urquidi J; Santos JL; Pérez H; Klaassen G
    Neuroepidemiology; 1999; 18(1):48-52. PubMed ID: 9831815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of APOE and other common genetic variants on the onset of Alzheimer's disease and dementia: a community-based cohort study.
    van der Lee SJ; Wolters FJ; Ikram MK; Hofman A; Ikram MA; Amin N; van Duijn CM
    Lancet Neurol; 2018 May; 17(5):434-444. PubMed ID: 29555425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of Alzheimer disease with the epsilon4 allele for apolipoprotein E in a population-based study of men aged 62-73 years.
    Breitner JC; Jarvik GP; Plassman BL; Saunders AM; Welsh KA
    Alzheimer Dis Assoc Disord; 1998 Mar; 12(1):40-4. PubMed ID: 9539409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic Downregulation of APOE, Polymorphic Variations of APOE, Diet, Social Isolation, and Co-morbidities as Contributing Factors to Alzheimer's Disease: a Case-Control Study of Kashmiri Population.
    Nissar K; Firdous P; Hussain A; Bashir S; Ahmad Z; Ganai BA
    Mol Neurobiol; 2023 Oct; 60(10):5891-5901. PubMed ID: 37357229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease.
    Craft S; Teri L; Edland SD; Kukull WA; Schellenberg G; McCormick WC; Bowen JD; Larson EB
    Neurology; 1998 Jul; 51(1):149-53. PubMed ID: 9674794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.
    Breitner JC; Wyse BW; Anthony JC; Welsh-Bohmer KA; Steffens DC; Norton MC; Tschanz JT; Plassman BL; Meyer MR; Skoog I; Khachaturian A
    Neurology; 1999 Jul; 53(2):321-31. PubMed ID: 10430421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOE genotype, memory test performance, and the risk of Alzheimer's disease in the Canadian Study of Health and Aging.
    Klages JD; Fisk JD; Rockwood K
    Dement Geriatr Cogn Disord; 2003; 15(1):1-5. PubMed ID: 12457072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association of APOE ε4 with cognitive function over the adult life course and incidence of dementia: 20 years follow-up of the Whitehall II study.
    Gharbi-Meliani A; Dugravot A; Sabia S; Regy M; Fayosse A; Schnitzler A; Kivimäki M; Singh-Manoux A; Dumurgier J
    Alzheimers Res Ther; 2021 Jan; 13(1):5. PubMed ID: 33397450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ACT/AA polymorphism could duplicate the APOE*epsilon4-associated Alzheimer's disease risk].
    Hernández-Charro B; Moreno S; Valiente A; Manubens JM; Villar MD; Ramos-Arroyo MA
    Med Clin (Barc); 2004 Sep; 123(7):251-4. PubMed ID: 15482730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.